ArticleScientific reports2025
Histopathological-based brain tumor grading using 2D-3D multi-modal CNN-transformer combined with stacking classifiers.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.MedComm · 2026Review
- Cross-attention guided explainable deep transformer model for multi-level classification of rare neurological disorders using MRI images.Scientific reports · 2026Article
- Explainable Artificial Intelligence in Healthcare: Current Landscape, Challenges, and Future Directions.Health science reports · 2026Review
- Explainable fusion of EfficientNetB0 and ResNet50 for liver fibrosis staging in ultrasound imaging.Scientific reports · 2025Article
- A Multimodal Adaptive Inter-Region Attention-Guided Network for Brain Tumor Classification.IEEE access : practical innovations, open solutions · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reliability in diagnosing and treating brain tumors depends on the accurate grading of histopathological images. However, limited scalability, adaptability, and interpretability challenge current methods for frequently grading brain tumors to accurately capture complex spatial relationships in histopathological images. This highlights the need for new approaches to overcome these shortcomings. This paper proposes a comprehensive hybrid learning architecture for brain tumor grading. Our pipeline uses complementary feature extraction techniques to capture domain-specific knowledge related to brain tumor morphology, such as texture and intensity patterns. An efficient method of learning hierarchical patterns within the tissue is the 2D-3D hybrid convolution neural network (CNN), which extracts contextual and spatial features. A vision transformer (ViT) additionally learns global relationships between image regions by concentrating on high-level semantic representations from image patches. Finally, a stacking ensemble machine learning classifier is fed concatenated features, allowing it to take advantage of the individual model's strengths and possibly enhance generalization. Our model's performance is evaluated using two publicly accessible datasets: TCGA and DeepHisto. Extensive experiments with ablation studies and cross-dataset evaluation validate the model's effectiveness, demonstrating significant gains in accuracy, precision, and specificity using cross-validation scenarios. In total, our brain tumor grading model outperforms existing methods, achieving an average accuracy, precision, and specificity of 97.1%, 97.1%, and 97.0%, respectively, on the TCGA dataset, and 95%, 94%, and 95% on DeepHisto dataset. Reported results demonstrate how the suggested architecture, which blends deep learning (DL) with domain expertise, can achieve reliable and accurate brain tumor grading.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.